Relearning Old Lessons
Sometimes you don’t realize how important something is until there’s a problem. Outsourcing is nothing new for the pharmaceutical industry, and many companies have come to rely on it. It helps companies stay lean and contributes toward profits.
Outsourcing is not a trouble-free strategy, however, as the contaminated heparin scandal attests. I can’t help but think that it was a careless attitude toward safety and quality standards that led to the problems. There is plenty of blame to go around. The drug company, the ingredient supplier, and regulators seem to have been asleep at the switch, and the results were both awful and avoidable.
This incident underscores what we already know: we need regulators to inspect ingredient suppliers and drug manufacturers to ensure that our medicines are safe and effective.
The problem is that sometimes we forget what we know. Read more »
Still think producing raw material overseas will reduce costs?
A recent Wall Street Journal blog post,